Opinion
Video
Implementing New IgAN Therapies Into Clinical Practice
Author(s):
Key Takeaways
- Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
- Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
Panelists discuss how the approval of atrasentan is expected to significantly affect the treatment landscape for IgA nephropathy by offering a novel therapeutic option that targets both proteinuria reduction and the underlying immune dysregulation associated with the disease.
- Please discuss the clinical implication and the effect on treatment landscape following the approval of atrasentan.
Related Videos
Related Content
